ABSTRACT

Drug Policy: Preliminary Observations on the 2022 National Drug Control Strategy, Statement of Triana McNeil, Director, Homeland Security and Justice, Testimony Before the Caucus on International Narcotics Control, U.S. Senate   [open pdf - 376KB]

From the Highlights: "Drug misuse--the use of illicit drugs and the misuse of prescription drugs--has been a persistent and long-standing public health challenge in the U.S. resulting in significant loss of life and a negative effect on society and the economy. These costs are borne by individuals who misuse drugs, as well as their families and employers, private businesses and nonprofit organizations, and federal, state, and local governments. GAO [Government Accountability Office] has a body of work on drug policy and ongoing work on ONDCP [Office of National Drug Control Policy]'s efforts, including issuance of the National Drug Control Strategy. This statement includes preliminary GAO observations on the 2022 National Drug Control Strategy and related findings from selected GAO reports on federal drug control-related efforts."

Report Number:
GAO-22-106087
Author:
Publisher:
Date:
2022-06-15
Copyright:
Public Domain
Retrieved From:
Government Accountability Office: https://www.gao.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations
Listed on Opioids [Featured Topic]